Hospital Segment tContribute Significantly tNon-invasive Aesthetic Treatment Market
According tour new research study on “Non-Invasive Aesthetic Treatment Market Forecast t2028 – COVID-19 Impact and Global Analysis – by Procedure and End User,” the market is expected treach US$ 18,656.54 million by 2028 from US$ 6,504.19 million in 2020; it is estimated tgrow at a CAGR of 14.2% from 2021 t2028. The report highlights trends prevailing in the market, and the factors driving and hindering the non-invasive aesthetic treatment market growth. The rising number of non-invasive aesthetic/cosmetic procedures performed every year, surge in awareness about cosmetic procedures among consumers, and availability of technologically advanced products are among the major forces boosting the market growth. However, clinical risks and complications associated with medical aesthetic procedures are limiting the market growth.
Non-invasive or non-surgical aesthetic treatment procedures dnot involve any surgical incision. In some cases, minimally invasive surgeries are alsconsidered as non-surgical procedures. A few of the commonly conducted non-invasive aesthetic treatments include botulinum toxin injection, chemical peels, non-surgical laser treatment, and microdermabrasion. Based on end user, the non-invasive aesthetic treatment market is segmented inthospitals, clinics and medical spas, and others. In 2020, the hospitals segment held the largest share of the market; it is further estimated tregister the highest CAGR of 14.9% during the forecast period.
The non-invasive aesthetic treatment market is witnessing slump amid the COVID-19 pandemic. Most healthcare research organizations and hospitals are engaged in introducing new products and solutions for the effective management of the disease. In addition, governments have issued guidelines for the rescheduling or suspension of all elective surgeries with an aim tfocus completely on handling the COVID-19 pandemic. This is hampering the demand for non-invasive aesthetic treatments, thus limiting the market growth.
Galderma SA, Alma Lasers, Merz Pharma, Bausch Health Companies Inc., Cutera Inc., Revance Therapeutics Inc., Cynosure, AbbVie Inc., Candela Medical, and Johnson and Johnson Services, Inc. are among the leading companies operating in the non-invasive aesthetic treatment market.
The report segments non-invasive aesthetic treatment market as follows:
By Procedure
- Injectables
- Botulinum Toxin
- Calcium Hydroxyapatite
- Hyaluronic Acid
- Polymer Filler
- Collagen
- Skin Rejuvenation
- Chemical Peel
- Laser Skin Resurfacing
- Photorejuvenation
- Others
- Hair Removal
- Nonsurgical Fat Reduction
- Sclerotherapy
- Cellulite Treatment
By End User
Hospitals
Clinics and Medical Spas
Others
By Geography
- North America
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of APAC
- Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Contact UsContact Person: Sameer JoshiPhone: +1-646-491-9876Email Id: sales@reportsweb.com
